Literature DB >> 19906396

Destabilization of Rb by human papillomavirus E7 is cell cycle dependent: E2-25K is involved in the proteolysis.

Kwang-Jin Oh1, Anna Kalinina, Srilata Bagchi.   

Abstract

The HPV oncoprotein E7 promotes proteasomal degradation of the tumor suppressor protein Rb. In this study, we analyzed the regulation of E7-induced Rb proteolysis in HPV-containing Caski cervical cancer cells. We show that the Rb proteolysis is cell cycle dependent; in S phase Rb is stable while in post-mitotic early G1 phase cells and in differentiated cells, Rb is unstable. Similarly, the in vivo Rb/E7 interaction is not detected in S-phase cells, but is readily detected in differentiating Caski cells. The ubiquitinating enzymes involved in Rb proteolysis have not been identified. We find that the E3 ligase MDM2 is not involved in the Rb proteolysis in Caski cells. An in vivo analysis using multiple catalytic site mutant dominant negative E2 enzymes show that the C92A E2-25K most effectively blocks E7-induced Rb proteolysis. Taken together, these results show that E7 induces Rb proteolysis in growth-arrested cells and E2-25K is involved in the proteolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906396      PMCID: PMC2796474          DOI: 10.1016/j.virol.2009.10.018

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

Review 1.  The ubiquitin-conjugation system.

Authors:  S Jentsch
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

Review 2.  Mechanisms of human papillomavirus-induced oncogenesis.

Authors:  Karl Münger; Amy Baldwin; Kirsten M Edwards; Hiroyuki Hayakawa; Christine L Nguyen; Michael Owens; Miranda Grace; Kyungwon Huh
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant.

Authors:  Peng Ji; Hong Jiang; Katya Rekhtman; Joanna Bloom; Marina Ichetovkin; Michele Pagano; Liang Zhu
Journal:  Mol Cell       Date:  2004-10-08       Impact factor: 17.970

4.  Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.

Authors:  H Higashitsuji; K Itoh; T Nagao; S Dawson; K Nonoguchi; T Kido; R J Mayer; S Arii; J Fujita
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

5.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.

Authors:  E Berezutskaya; B Yu; A Morozov; P Raychaudhuri; S Bagchi
Journal:  Cell Growth Differ       Date:  1997-12

6.  Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme.

Authors:  M A Kalchman; R K Graham; G Xia; H B Koide; J G Hodgson; K C Graham; Y P Goldberg; R D Gietz; C M Pickart; M R Hayden
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

7.  Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis.

Authors:  D L Jones; D A Thompson; K Münger
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

8.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

Authors:  S N Boyer; D E Wazer; V Band
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

Review 9.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

Review 10.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

View more
  12 in total

1.  How Do Intrinsically Disordered Viral Proteins Hijack the Cell?

Authors:  H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2018-06-28       Impact factor: 3.162

2.  Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein.

Authors:  Nicholas J Genovese; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  Interaction and co-localization of JC virus large T antigen and the F-box protein β-transducin-repeat containing protein.

Authors:  Marta M Reviriego-Mendoza; Richard J Frisque
Journal:  Virology       Date:  2010-11-23       Impact factor: 3.616

4.  John Cunningham virus T-antigen expression in anal carcinoma.

Authors:  Sonia Ramamoorthy; Bikash Devaraj; Katsumi Miyai; Linda Luo; Yu-Tsueng Liu; C Richard Boland; Ajay Goel; John M Carethers
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

5.  A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor.

Authors:  Yingshuang Wang; Zongfang Zheng; Jingyi Zhang; You Wang; Ruirui Kong; Jiangying Liu; Ying Zhang; Hongkui Deng; Xiaojuan Du; Yang Ke
Journal:  J Biol Chem       Date:  2015-10-06       Impact factor: 5.157

6.  Further Stimulation of Cellular Immune Responses through Association of HPV-16 E6, E7 and L1 Genes in order to produce more Effective Therapeutic DNA Vaccines in Cervical Cancer Model.

Authors:  Maryam Fazeli; Hoorieh Soleimanjahi; Simin Dadashzadeh
Journal:  Iran J Cancer Prev       Date:  2015 Jan-Feb

Review 7.  The role of ubiquitin and ubiquitin-like modification systems in papillomavirus biology.

Authors:  Van G Wilson
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

8.  Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth.

Authors:  Juan Li; Jie Liu; Zheyong Liang; Fang He; Lu Yang; Pingping Li; Yina Jiang; Bo Wang; Can Zhou; Yaochun Wang; Yu Ren; Jin Yang; Jianmin Zhang; Zhijun Luo; Cyrus Vaziri; Peijun Liu
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

9.  E2-25K SUMOylation inhibits proteasome for cell death during cerebral ischemia/reperfusion.

Authors:  Eun Il Jeong; Hae Won Chung; Won Jea Lee; Seo-Hyun Kim; Hyunjoo Kim; Seon-Guk Choi; Yong-Keun Jung
Journal:  Cell Death Dis       Date:  2016-12-29       Impact factor: 8.469

10.  Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model.

Authors:  Donia Alson; Scott C Schuyler; Bo-Xin Yan; Karthika Samimuthu; Jiantai Timothy Qiu
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.